Rheumatoid Arthritis
Largest, most representative RA data registry available for licensing, analytics, and collaboration
Research-Grade RWD in RA
Unmet Need
Disease with no cure
With no cure for RA, early diagnosis and effective treatment are the best ways to help reduce damaging effects and improve patients’ quality of life.
Deep Clinical Data
239,700+*
RA patients followed prospectively with deep clinical, lab, and other linked data
*Counts are based on Q2 2023 registry release
Analytics & Modeling
1.9 Million+*
RA patients in the OM1 Real-World Data Cloud that can be used for modeling, analysis, and other research purposes
WEBINAR: Real-World Data for R&D for Autoimmune & Chronic Diseases
View webinar to learn more.
Abstracts & Posters
- Poster (ACR Convergence 2021): A Cross-Sectional Study of Rheumatoid Arthritis (RA) Diagnoses in Patients with Systemic Lupus Erythematosus (SLE)
- Publication (RMD Open, Nov 2021): Validation of a Machine Learning Approach to Estimate Clinical Disease Activity Index Scores for Rheumatoid Arthritis
- Poster (EULAR 2021): Patient Characteristics and Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: The OM1 RA Registry
- Article (Osteoporosis International, July 2020): Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
- Poster (ICPE 2019): Improvements in Disease Activity Scores Associated with bDMARD use by Rheumatoid Arthritis Patients in a Large US-Based Real World Cohort
- Poster (AMCP 2019): Age and Gender Differences in Comorbidities among Patients with Rheumatoid Arthritis in a Large US-Based Real World Cohort
(continued)
- Poster (ISPOR 2019): Depression and Patient Outcomes Among Rheumatoid Arthritis Patients in a Large US-Based Real World Cohort
- Poster (ACR/ARHP 2017): Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort
- Abstract (ACR/ARHP 2017): Comparison of Improvements in Disease Activity between Classes of Biologic Disease Modifying Anti-Rheumatic Drugs in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort
- Poster (ISPOR 2017): Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Next Generation Registry
- Poster (ISPOR 2017): Patient Reported Outcomes and Changes in DMARD Therapy for Rheumatoid Arthritis in Routine Clinical Practice